Biofilms may be present in up to 80% of chronic wounds and play a significant role in impeding the healing process. Removal of the microbial bioburden is essential to facilitate healing.
DEBRICHEM is a single-use medical device that is designed to remove the microbial bioburden in infected, chronic wounds in a single 60-second application.
With over 90% of cases requiring just one treatment, the solution is designed to not require a certificate in sharp debridement, and can be applied in any healthcare setting. After treatment, the devitalised tissue and biofilm slough off in several days, preparing the wound for healing.
A UK study looking at venous leg ulcer management demonstrated a 75% increase in the probability of healing, and an overall 57% reduction in healthcare-related costs for cases treated with DEBRICHEM plus standard of care (SOC) compared to cases treated with SOC alone. Improvements in the patient’s healthcare-related quality of life were also observed.
The full reference list is available here: www.gaiamedical.com.au/references.
For more information, visit https://bit.ly/4h2C0b2, or phone 02 5133 7000 or 0472 752 575.